Growth Metrics

Neuroone Medical Technologies (NMTC) Shares Outstanding (Weighted Average) (2010 - 2026)

Neuroone Medical Technologies posted quarterly Shares Outstanding (Weighted Average) of $8.5 million for Q1 2026, up 64.37% year-on-year from $5.2 million in Q1 2025, and down 83.14% on a QoQ basis from $50.3 million in Q4 2025.

Neuroone Medical Technologies (NMTC) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $8.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 64.37% year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2026 stood at $8.5 million (up 64.37% YoY), and the FY2025 full-year result was $100000.0, down 99.63% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $8.5 million, down from $50.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $50.3 million in Q4 2025 and bottomed at $100000.0 in Q3 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $16.3 million (2023), against an average of $19.6 million.
  • The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) surged 7715.05%; it then tumbled 99.63% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $16.2 million in 2022, then jumped by 47.84% to $24.0 million in 2023, then advanced by 28.51% to $30.8 million in 2024, then soared by 63.21% to $50.3 million in 2025, then tumbled by 83.14% to $8.5 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $8.5 million (Q1 2026), $50.3 million (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.74 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 382.90 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 456.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 98.20 Mn
10 Neuroone Medical Technologies 31.39 Mn 28.59 Mn 1.29 Mn 8.48 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8.48 Mn
Dec 31, 2025 50.33 Mn
Sep 30, 2025 100,000.00
Jun 30, 2025 36.85 Mn
Mar 31, 2025 5.16 Mn
Dec 31, 2024 30.84 Mn
Sep 30, 2024 26.76 Mn
Jun 30, 2024 27.35 Mn
Mar 31, 2024 24.95 Mn
Dec 31, 2023 24.00 Mn
Sep 30, 2023 18.12 Mn
Jun 30, 2023 350,000.00
Mar 31, 2023 16.32 Mn
Dec 31, 2022 16.23 Mn
Sep 30, 2022 16.00 Mn
Jun 30, 2022 15.93 Mn
Mar 31, 2022 16.19 Mn
Dec 31, 2021 15.41 Mn
Sep 30, 2021 10.70 Mn
Jun 30, 2021 10.27 Mn
Mar 31, 2021 9.42 Mn
Dec 31, 2020 7.68 Mn
Sep 30, 2020 5.42 Mn
Jun 30, 2020 5.35 Mn
Mar 31, 2020 4.59 Mn
Dec 31, 2019 13.66 Mn
Sep 30, 2019 11.86 Mn
Jun 30, 2019 11.31 Mn
Mar 31, 2019 221,074.00
Dec 31, 2018 9.76 Mn
Sep 30, 2018 8.42 Mn
Jun 30, 2018 7.90 Mn
Mar 31, 2018 7.86 Mn
Dec 31, 2017 7.86 Mn
Sep 30, 2017 7.86 Mn
Jun 30, 2017 5.87 Mn
Mar 31, 2017 5.22 Mn
Dec 31, 2016 4.42 Mn
Sep 30, 2016 1.66 Mn
Jun 30, 2016 5.07 Mn
Mar 31, 2016 5.07 Mn
Dec 31, 2015 5.07 Mn
Sep 30, 2015 5.07 Mn
Jun 30, 2015 5.07 Mn
Mar 31, 2015 5.07 Mn
Dec 31, 2014 5.07 Mn
Jun 30, 2014 5.07 Mn
Mar 31, 2014 5.07 Mn
Dec 31, 2013 5.07 Mn
Sep 30, 2013 4.50 Mn
Jun 30, 2013 4.50 Mn
Mar 31, 2013 5.07 Mn
Dec 31, 2012 5.07 Mn
Sep 30, 2012 4.50 Mn
Jun 30, 2012 4.50 Mn
Mar 31, 2012 5.07 Mn
Dec 31, 2011 4.64 Mn
Sep 30, 2011 4.54 Mn
Jun 30, 2011 4.50 Mn
Mar 31, 2011 4.50 Mn
Dec 31, 2010 4.29 Mn
Sep 30, 2010 4.22 Mn